Fingolimod D4
| Product Name | Fingolimod D4 |
|---|---|
| Alternate Names | Fingolimod Stable Isotopes, Stable Isotopes of Fingolimod |
| CAT No. | CS-O-02993 |
| CAS No. | 1346747-38-3 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 311.5 g/mol |
| Mol. For. | C19H29D4NO2 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Fingolimod |
| Purity | 99.04 |
| Therapeutic | Immunosuppressants |
| Smileys | NC(C([2H])([2H])O)(C([2H])([2H])O)CCC1=CC=C(CCCCCCCC)C=C1 |
| Canonical Smiles | CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N |
| InchIKey | KKGQTZUTZRNORY-ONNKGWAKSA-N |
| Inchl | InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3/i15D2,16D2 |
| IUPAC | 2-amino-1,1,3,3-tetradeuterio-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Fingolimod D4 is a deuterated form of fingolimod, which is a medication used in the treatment of multiple sclerosis (MS). MS is a chronic autoimmune disease that affects the central nervous system, leading to inflammation, demyelination, and ultimately, neurological dysfunction. Fingolimod D4 works by binding to sphingosine 1-phosphate receptors in the body, which helps to reduce the number of lymphocytes that can enter the central nervous system and cause damage.
Fingolimod D4 is available in capsule form and is usually taken orally once a day. It is essential to follow the dosage instructions provided by the doctor. The medication should not be stopped suddenly, as this can lead to a rebound effect, causing a severe flare-up of MS symptoms. Fingolimod D4 can cause side effects, including headache, fatigue, diarrhea, and liver problems. Patients should inform their doctors if they have a history of heart problems or have had recent infections before starting the medication.
Fingolimod D4 is a synthetic compound that is structurally related to sphingosine, a natural lipid in the body. The deuterium substitution in fingolimod D4 improves pharmacokinetic properties and increases the half-life of the medication in the body. The molecular formula of fingolimod D4 is C19H35D4NO2, and its molecular weight is 324.58 g/mol. The medication is available as a white to off-white powder and has a melting point of 101-102°C. Overall, Fingolimod D4 is an important medication in the treatment of MS and can help improve the quality of life of patients suffering from this debilitating disease.
Get an Instant Quote
Related Compounds
Fingolimod phosphate D4 HCl | Fingolimod phosphate D4 |